124 related articles for article (PubMed ID: 20506100)
1. Failure of the GORE HELEX atrial septal defect occluder to treat membranous VSDs in swine.
Hagler DJ; Latson LA; Goble J; Mathewson JW; Cutright W
Catheter Cardiovasc Interv; 2010 Nov; 76(6):874-7. PubMed ID: 20506100
[TBL] [Abstract][Full Text] [Related]
2. Failed closure of a ventricular septal defect with an Amplatzer occluder.
Wippermann J; Hoppe UC; Sreeram N; Wahlers T
Interact Cardiovasc Thorac Surg; 2010 Feb; 10(2):320-1. PubMed ID: 19914923
[TBL] [Abstract][Full Text] [Related]
3. Transcatheter closure of the perimembranous ventricular septal defect-preclinical trial of a new Amplatzer device.
Bass JL; Gruenstein D
Catheter Cardiovasc Interv; 2012 Jun; 79(7):1153-60. PubMed ID: 22162409
[TBL] [Abstract][Full Text] [Related]
4. Transcatheter closure of membranous ventricular septal defects with a new nitinol prosthesis in a natural swine model.
Gu X; Han YM; Titus JL; Amin Z; Berry JM; Kong H; Rickers C; Urness M; Bass JL
Catheter Cardiovasc Interv; 2000 Aug; 50(4):502-9. PubMed ID: 10931631
[TBL] [Abstract][Full Text] [Related]
5. Transcatheter closure of a membranous ventricular septal defect in a 1.8-kg infant using Amplatzer Duct Occluder II additional size device.
Champaneri B; Kappanayil M; Kumar RK
Cardiol Young; 2017 Sep; 27(7):1437-1440. PubMed ID: 28506322
[TBL] [Abstract][Full Text] [Related]
6. Results of the U.S. Food and Drug Administration continued access clinical trial of the GORE HELEX septal occluder for secundum atrial septal defect.
Javois AJ; Rome JJ; Jones TK; Zahn EM; Fleishman CE; Pignatelli RH; Latson LA;
JACC Cardiovasc Interv; 2014 Aug; 7(8):905-12. PubMed ID: 25147036
[TBL] [Abstract][Full Text] [Related]
7. Combined prospective United States clinical study data for the GORE(®) HELEX(®) septal occluder device.
Rhodes JF; Goble J
Catheter Cardiovasc Interv; 2014 May; 83(6):944-52. PubMed ID: 23674380
[TBL] [Abstract][Full Text] [Related]
8. Closure of multiple fenestrations in an aneurismal atrial septum using overlapping GORE HELEX septal occluders.
Lockhart CJ; Magee AG
Catheter Cardiovasc Interv; 2012 Jun; 79(7):1176-7. PubMed ID: 22109833
[TBL] [Abstract][Full Text] [Related]
9. Development and preclinical evaluation of a biodegradable ventricular septal defect occluder.
Huang XM; Zhu YF; Cao J; Hu JQ; Bai Y; Jiang HB; Li ZF; Chen Y; Wang W; Qin YW
Catheter Cardiovasc Interv; 2013 Feb; 81(2):324-30. PubMed ID: 22888016
[TBL] [Abstract][Full Text] [Related]
10. First experience with the new GORE Septal Occluder for the closure of multiple atrial septal defects.
Freixa X; Garceau P; Asgar AW
Catheter Cardiovasc Interv; 2013 Jun; 81(7):1238-42. PubMed ID: 22639117
[TBL] [Abstract][Full Text] [Related]
11. Intraoperative device closure of perimembranous ventricular septal defects without cardiopulmonary bypass: preliminary results with the perventricular technique.
Amin Z; Danford DA; Lof J; Duncan KF; Froemming S
J Thorac Cardiovasc Surg; 2004 Jan; 127(1):234-41. PubMed ID: 14752435
[TBL] [Abstract][Full Text] [Related]
12. Early migration of an Amplatzer muscular ventricular septal defect occluder device causing severe tricuspid valve obstruction.
Panduranga P; Al-Farqani A; Al-Maskari S
J Cardiovasc Med (Hagerstown); 2012 May; 13(5):336-7. PubMed ID: 22089813
[TBL] [Abstract][Full Text] [Related]
13. Transcatheter closure of perimembranous ventricular septal defects: initial human experience with the Amplatzer® membranous VSD occluder 2.
Velasco-Sanchez D; Tzikas A; Ibrahim R; Miró J
Catheter Cardiovasc Interv; 2013 Sep; 82(3):474-9. PubMed ID: 22431366
[TBL] [Abstract][Full Text] [Related]
14. Closure of perimembranous ventricular septal defects with aneurysmal tissue using the Amplazter Duct Occluder I: lessons learned and medium term follow up.
El Said HG; Bratincsak A; Gordon BM; Moore JW
Catheter Cardiovasc Interv; 2012 Nov; 80(6):895-903. PubMed ID: 22907908
[TBL] [Abstract][Full Text] [Related]
15. Perventricular device closure of perimembranous ventricular septal defects in 61 young children: early and midterm follow-up results.
Tao K; Lin K; Shi Y; Song H; Lui RC; Gan C; An Q
J Thorac Cardiovasc Surg; 2010 Oct; 140(4):864-70. PubMed ID: 20561638
[TBL] [Abstract][Full Text] [Related]
16. [The morphologic changes of Amplatzer asymmetric ventricular septal defect occluder after transcatheter closure of perimembrane ventricular septal defect].
Ma YT; Yang YN; Tang BP; Huang D; Mu YM; Ma X; Liu X
Zhonghua Er Ke Za Zhi; 2004 Nov; 42(11):817-20. PubMed ID: 15631704
[TBL] [Abstract][Full Text] [Related]
17. Very Late Dislocation of an AMPLATZER Septal Occluder Device Suspected Thanks to a Recent Onset of Right-Axis Deviation.
Dendramis G; Paleologo C; Piraino D; Augugliaro S
JACC Cardiovasc Interv; 2016 Apr; 9(8):859-860. PubMed ID: 27101912
[No Abstract] [Full Text] [Related]
18. Device closure of iatrogenic membranous ventricular septal defects after prosthetic aortic valve replacement using the Amplatzer membranous ventricular septal defect occluder.
Holzer R; Latson L; Hijazi ZM
Catheter Cardiovasc Interv; 2004 Jun; 62(2):276-80. PubMed ID: 15170726
[TBL] [Abstract][Full Text] [Related]
19. Transcatheter closure of perimembranous ventricular septal defects using amplatzer asymmetric ventricular septal defect occluder: preliminary experience with 18-month follow up.
Pinto RJ; Dalvi BV; Sharma S
Catheter Cardiovasc Interv; 2006 Jul; 68(1):145-52. PubMed ID: 16763998
[TBL] [Abstract][Full Text] [Related]
20. Novel transcatheter closure of an iatrogenic perimembranous ventricular septal defect.
Retzer EM; Dill KE; Shah AP
Catheter Cardiovasc Interv; 2015 Jan; 85(1):161-5. PubMed ID: 25176592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
